The Patent Finder

Ani Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Ani Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.

Showing 1 to 6 of 6 · Back to Ani Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 11,696,906Stable Oral Suspensions of Baclofen
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 11,857,524Stable Oral Suspensions of Baclofen
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 7,858,662Medicament for the treatment of viral skin and tumour diseases
Term ended
Term ended Oct 2, 2026 · From the USPTO record
Term endedTerm ended Oct 2, 2026From the USPTO record
US 9,770,406Medicament for the treatment of viral skin and tumour diseases
Term ended
Term ended Jul 12, 2025 · From the USPTO record
Term endedTerm ended Jul 12, 2025From the USPTO record
US 10,434,059Medicament for the treatment of viral skin and tumour diseases
Term ended
Ended no later than Nov 18, 2022 · From the USPTO record
Term endedEnded no later than Nov 18, 2022From the USPTO record
US 6,319,494Chimeric chains for receptor-associated signal transduction pathways
Formerly held
Term ended
Term ended Nov 20, 2018 · From the USPTO record
Term endedTerm ended Nov 20, 2018From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited